Release Notes:
Data Element
Version 2016B1
| Data Element Name: | Nimodipine Administration |
|---|
| Collected For: | CSTK-06, |
|---|
| Definition: | Documentation that nimodipine was administered at this hospital. Nimodipine is a cerebroselective calcium channel blocker that inhibits calcium transport into vascular smooth muscle cells, thereby suppressing contractions. Nimodipine is used in the treatment of subarachnoid hemorrhage patients to prevent or limit the severity of cerebral vasospasm. |
|---|
| Suggested Data Collection Question: | Is there documentation that nimodipine was administered at this hospital? |
|---|
| Format: | | Length: | 1 |
|---|
| Type: | Alphanumeric |
|---|
| Occurs: | 1 |
|---|
|
|---|
| Allowable Values: |
Y (Yes) Nimodipine was administered at this hospital.
N (No) Nimodipine was not administered at this hospital,OR unable to determine from medical record documentation.
|
|---|
| Notes for Abstraction: |
- Nimodipine treatment must be administered at this hospital within the first 24 hours of arrival to select 'YES'. It is not necessary to review documentation outside of this timeframe.
- If nimodipine was administered at another hospital and the patient was subsequently transferred to this hospital and nimodipine treatment continued on admission to this hospital, select 'YES'.
- If nimodipine was administered at this hospital later than the first 24 hours after arrival, select 'NO'.
- If nimodipine was administered at another hospital and the patient was subsequently transferred to this hospital and nimodipine treatment was not resumed or discontinued, select 'NO'.
- A physician order for nimodipine that is not executed, select 'NO'.
|
|---|
| Suggested Data Sources: |
- Emergency department record
- Nursing flow sheet
- Progress notes
- Medication administration record (MAR)
- Medical transport records
- Medication reconciliation form
|
|---|
| Additional Notes: |
|
|---|
| Guidelines for Abstraction: |
|---|
| Inclusion | Exclusion |
- Nimodipine
- Nimotop
- Nymalize
|
All other calcium channel blocker medications other than those listed as inclusions. |
|
Nimodipine Administration
Specifications Manual for Joint Commission National Quality Measures (v2016B1)
Discharges 01-01-17 (1Q17) through 06-30-17 (2Q17)
^
Warning: your browser isn't supported. Please install a modern one, like Firefox, Opera, Safari, Chrome or the latest Internet Explorer.
Thank you!